BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 28523839)

  • 21. Pharmacological treatment algorithms for the acute phase, agitation, and maintenance phase of first-episode schizophrenia: Japanese Society of Clinical Neuropsychopharmacology treatment algorithms.
    Takeuchi H; Takekita Y; Hori H; Oya K; Miura I; Hashimoto N; Yasui-Furukori N
    Hum Psychopharmacol; 2021 Nov; 36(6):e2804. PubMed ID: 34241916
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Level of serum thioredoxin and correlation with neurocognitive functions in patients with schizophrenia using clozapine and other atypical antipsychotics.
    Bas A; Gultekin G; Incir S; Bas TO; Emul M; Duran A
    Psychiatry Res; 2017 Jan; 247():84-89. PubMed ID: 27871032
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clozapine for treatment-resistant schizophrenia: National Institute of Clinical Excellence (NICE) guidance in the real world.
    Mortimer AM; Singh P; Shepherd CJ; Puthiryackal J
    Clin Schizophr Relat Psychoses; 2010 Apr; 4(1):49-55. PubMed ID: 20643629
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Childhood-onset schizophrenia: A double-blind, randomized clozapine-olanzapine comparison.
    Shaw P; Sporn A; Gogtay N; Overman GP; Greenstein D; Gochman P; Tossell JW; Lenane M; Rapoport JL
    Arch Gen Psychiatry; 2006 Jul; 63(7):721-30. PubMed ID: 16818861
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of Early Clozapine Treatment on Remission Rates in Acute Schizophrenia (The EARLY Trial): Protocol of a Randomized-Controlled Multicentric Trial.
    Wagner E; Strube W; Görlitz T; Aksar A; Bauer I; Campana M; Moussiopoulou J; Hapfelmeier A; Wagner P; Egert-Schwender S; Bittner R; Eckstein K; Nenadić I; Kircher T; Langguth B; Meisenzahl E; Lambert M; Neff S; Malchow B; Falkai P; Hirjak D; Böttcher KT; Meyer-Lindenberg A; Blankenstein C; Leucht S; Hasan A
    Pharmacopsychiatry; 2023 Sep; 56(5):169-181. PubMed ID: 37506738
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An open, large, 6-month naturalistic study of outcome in schizophrenic outpatients, treated with olanzapine.
    Krzystanek M; Krupka-Matuszczyk I
    Hum Psychopharmacol; 2011 Jan; 26(1):81-5. PubMed ID: 23055416
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Changes in glucose and cholesterol levels in patients with schizophrenia treated with typical or atypical antipsychotics.
    Lindenmayer JP; Czobor P; Volavka J; Citrome L; Sheitman B; McEvoy JP; Cooper TB; Chakos M; Lieberman JA
    Am J Psychiatry; 2003 Feb; 160(2):290-6. PubMed ID: 12562575
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative Effectiveness of Clozapine and Standard Antipsychotic Treatment in Adults With Schizophrenia.
    Stroup TS; Gerhard T; Crystal S; Huang C; Olfson M
    Am J Psychiatry; 2016 Feb; 173(2):166-73. PubMed ID: 26541815
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Real-World Effectiveness of Antipsychotic Treatments in a Nationwide Cohort of 29 823 Patients With Schizophrenia.
    Tiihonen J; Mittendorfer-Rutz E; Majak M; Mehtälä J; Hoti F; Jedenius E; Enkusson D; Leval A; Sermon J; Tanskanen A; Taipale H
    JAMA Psychiatry; 2017 Jul; 74(7):686-693. PubMed ID: 28593216
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Pharmacotherapy of schizophrenia].
    Correll CU
    Nervenarzt; 2020 Jan; 91(1):34-42. PubMed ID: 31919550
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Predictors of Treatment-Resistant and Clozapine-Resistant Schizophrenia: A 12-Year Follow-up Study of First-Episode Schizophrenia-Spectrum Disorders.
    Chan SKW; Chan HYV; Honer WG; Bastiampillai T; Suen YN; Yeung WS; Lam M; Lee WK; Ng RMK; Hui CLM; Chang WC; Lee EHM; Chen EYH
    Schizophr Bull; 2021 Mar; 47(2):485-494. PubMed ID: 33043960
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Atypical antipsychotic drugs as a first-line treatment of schizophrenia: a rationale and hypothesis.
    Lieberman JA
    J Clin Psychiatry; 1996; 57 Suppl 11():68-71. PubMed ID: 8941173
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Resistance is not futile: treatment-refractory schizophrenia - overview, evaluation and treatment.
    Faden J; Citrome L
    Expert Opin Pharmacother; 2019 Jan; 20(1):11-24. PubMed ID: 30407873
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clozapine Use in a Cohort of First-Episode Psychosis.
    Doyle R; Behan C; OʼKeeffe D; Masterson S; Kinsella A; Kelly A; Sheridan A; Keating D; Hynes C; Madigan K; Lawlor E; Clarke M
    J Clin Psychopharmacol; 2017 Oct; 37(5):512-517. PubMed ID: 28650930
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Incidence and predictors of acute akathisia in severely ill patients with first-episode schizophrenia treated with aripiprazole or risperidone: secondary analysis of an observational study.
    Yoshimura B; Sato K; Sakamoto S; Tsukahara M; Yoshimura Y; So R
    Psychopharmacology (Berl); 2019 Feb; 236(2):723-730. PubMed ID: 30443794
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Outcomes of medicaid beneficiaries with schizophrenia receiving clozapine only or antipsychotic combinations.
    Velligan DI; Carroll C; Lage MJ; Fairman K
    Psychiatr Serv; 2015 Feb; 66(2):127-33. PubMed ID: 25321616
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Atypical and conventional antipsychotic drugs in treatment-naive first-episode schizophrenia: a 52-week randomized trial of clozapine vs chlorpromazine.
    Lieberman JA; Phillips M; Gu H; Stroup S; Zhang P; Kong L; Ji Z; Koch G; Hamer RM
    Neuropsychopharmacology; 2003 May; 28(5):995-1003. PubMed ID: 12700715
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Does adding a second antipsychotic to clozapine improve clinical response in resistant schizophrenia?
    Jiménez-Cornejo M; Munizaga G; Aceituno D
    Medwave; 2016 Dec; 16(Suppl5):e6614. PubMed ID: 27922589
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Correlation between delay in initiating clozapine and symptomatic improvement.
    Yada Y; Yoshimura B; Kishi Y
    Schizophr Res; 2015 Oct; 168(1-2):585-6. PubMed ID: 26255084
    [No Abstract]   [Full Text] [Related]  

  • 40. Betahistine effects on weight-related measures in patients treated with antipsychotic medications: a double-blind placebo-controlled study.
    Smith RC; Maayan L; Wu R; Youssef M; Jing Z; Sershen H; Szabo V; Meyers J; Jin H; Zhao J; Davis JM
    Psychopharmacology (Berl); 2018 Dec; 235(12):3545-3558. PubMed ID: 30382354
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.